Publication

Tumor-specific activation of prodrugs: Is there a role for nuclear medicine?

Farinha Antunes, I., Haisma, H. J. & de Vries, E. F. J., Oct-2008, In : Nuclear Medicine Communications. 29, 10, p. 845-846 2 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Copy link to clipboard

Documents

  • Tumor-specific activation of prodrugs: is there a role for nuclear medicine?

    Final publisher's version, 51 KB, PDF document

DOI

Original languageEnglish
Pages (from-to)845-846
Number of pages2
JournalNuclear Medicine Communications
Volume29
Issue number10
Publication statusPublished - Oct-2008

    Keywords

  • PRONOUNCED ANTITUMOR EFFICACY, BETA-GLUCURONIDASE, ANTICANCER PRODRUGS, GENE-THERAPY, ENZYME, CANCER, DOXORUBICIN, PET

ID: 4778377